BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11013644)

  • 1. Treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma.
    Latif AZ; Signorini DF; Whittle IR
    Br J Neurosurg; 1998 Feb; 12(1):29-32. PubMed ID: 11013644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment by specialist surgical neurooncologists improves survival times for patients with malignant glioma.
    Khan UA; Bhavsar A; Asif H; Karabatsou K; Leggate JR; Sofat A; Kamaly-Asl ID
    J Neurosurg; 2015 Feb; 122(2):297-302. PubMed ID: 25415070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
    Latif AZ; Signorini D; Gregor A; Grant R; Ironside JW; Whittle IR
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):747-50. PubMed ID: 9647303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.
    Vecht CJ; Avezaat CJ; van Putten WL; Eijkenboom WM; Stefanko SZ
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):466-71. PubMed ID: 2166137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
    Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
    Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
    Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant brain glioma--a catamnestic study of 100 operated patients].
    Victor S; Lausberg G
    Zentralbl Neurochir; 1991; 52(2):59-68. PubMed ID: 1659065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in radiotherapy shortens survival in patients with high grade glioma.
    Irwin C; Hunn M; Purdie G; Hamilton D
    J Neurooncol; 2007 Dec; 85(3):339-43. PubMed ID: 17579810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mobile and cordless phones and survival of patients with glioma.
    Hardell L; Carlberg M
    Neuroepidemiology; 2013; 40(2):101-8. PubMed ID: 23095687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.
    Rusthoven KE; Olsen C; Franklin W; Kleinschmidt-DeMasters BK; Kavanagh BD; Gaspar LE; Lillehei K; Waziri A; Damek DM; Chen C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):211-7. PubMed ID: 20732762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery.
    Wang YY; Yang GK; Li SY; Baol XF; Wu CY
    Chin Med Sci J; 2004 Jun; 19(2):105-10. PubMed ID: 15250245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of managing patients with malignant glioma at a neuro-oncology clinic.
    Latif AZ; Signorini D; Gregor A; Whittle IR
    Br J Neurosurg; 1998 Apr; 12(2):118-22. PubMed ID: 11013662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined treatment with neurosurgery-radiotherapy of malignant brain tumors].
    Fried H; Feyer P
    Zentralbl Neurochir; 1990; 51(4):208-11. PubMed ID: 1965936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
    Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
    World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
    Urtasun RC; Cosmatos D; DelRowe J; Kinsella TJ; Lester S; Wasserman T; Fulton DS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):207-14. PubMed ID: 8407393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.